MORINAGA MILK

News

August 30, 2024
Notice of Signing of "Mizuho Eco Finance" Agreement with Mizuho Bank, Ltd.
August 23, 2024
Announcement regarding conclusion of Memorandum of Understanding with Indonesian government agency in relation to Joint clinical testing and standardization project
August 09, 2024
Notice Regarding Completion of Payment for Disposal of Treasury Stock as Restricted Stock Compensation
August 08, 2024
Announcement of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2025.
August 06, 2024
Bifidobacterium longum subsp. infantis M-63 registered as a “New Food Ingredient” in China
July 29, 2024
Notice Regarding Repricing of Certain Household Ice Cream and Cheeses
July 18, 2024
Notice Regarding Disposal of Treasury Stock as Restricted Stock Compensation
June 07, 2024
Notice Regarding Acquisition of Treasury Stock and Temporary Suspension of Acquisition (Actions associated with the Introduction of a Stock Provision Trust (J-ESOP))
May 30, 2024
Notice Concerning Decision of Issuance Conditions of 19th series of unsecured straight bonds of Morinaga Milk Industry Co., Ltd. (with Inter-bond Pari Passu Clauses)(Green Bonds) and 20th series of unsecured straight bonds of Morinaga Milk Industry Co., Ltd. (with Inter-bond Pari Passu Clauses)
May 30, 2024

No. 1 company in the world for articles on Bifidobacterium resident in humans*1 Morinaga Milk and Kyoto University have confirmed that Human-Residential Bifidobacteria (HRB) can convert indole, a uremic toxin precursor, into indole-3-lactic acid (ILA) which is beneficial to the body Published in Scientific Journal “Gut Microbes”
TOP